Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML

In acute myeloid leukemia (AML) many patients experience relapse, despite the achievement of morphological complete remission; therefore, conventional morphologic criteria are currently considered inadequate for assessing the quality of the response after treatment. Quantification of measurable resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Meddi, Elisa, Savi, Arianna, Moretti, Federico, Mallegni, Flavia, Palmieri, Raffaele, Paterno, Giovangiacinto, Buzzatti, Elisa, Del Principe, Maria Ilaria, Buccisano, Francesco, Venditti, Adriano, Maurillo, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967250/
https://www.ncbi.nlm.nih.gov/pubmed/36834477
http://dx.doi.org/10.3390/ijms24043062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967250/
https://www.ncbi.nlm.nih.gov/pubmed/36834477
http://dx.doi.org/10.3390/ijms24043062

Ejemplares similares